Transduction of dendritic cells with recombinant adenovirus encoding HCA661 activates autologous cytotoxic T lymphocytes to target hepatoma cells

British Journal of Cancer

Volumn 90, Issue 8, 2004, Pages 1636-1643

  Chan, R C F ^a   Pang, X W ^b   Wang, Y D ^b   Chen, W F ^b   Xie, Y ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Cytotoxic T lymphocytes; Dendritic cell; HCA661; Hepatocellular carcinoma; Hepatoma; Liver cancer; Recombinant adenovirus; Tumour vaccine

Indexed keywords

ADENOVIRUS VECTOR; ANTIGEN; B7 ANTIGEN; CANCER TESTIS ANTIGEN; CD38 ANTIGEN; CD86 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA A2 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 4; MESSENGER RNA; COMPLEMENTARY DNA; TUMOR ANTIGEN;

ARTICLE; CANCER IMMUNOLOGY; CANCER IMMUNOTHERAPY; CELL ACTIVATION; CELL DIFFERENTIATION; CELL MATURATION; CELL STRAIN HEPG2; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSDUCTION; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE; TESTIS; VIRUS RECOMBINANT; ADENOVIRUS; CULTURE MEDIUM; CULTURE TECHNIQUE; GENETICS; IMMUNOLOGY; IMMUNOTHERAPY; LIVER TUMOR; LYMPHOCYTE ACTIVATION; METHODOLOGY; MONOCYTE; PATHOLOGY; PHENOTYPE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOVIRIDAE; ANTIGENS, NEOPLASM; CARCINOMA, HEPATOCELLULAR; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CULTURE MEDIA; DENDRITIC CELLS; DNA, COMPLEMENTARY; FLOW CYTOMETRY; HUMANS; IMMUNOTHERAPY; LIVER NEOPLASMS; LYMPHOCYTE ACTIVATION; MONOCYTES; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, CYTOTOXIC; TRANSDUCTION, GENETIC;

EID: 2442595061     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601706     Document Type: Article

References (35)

1. 5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med 188: 1359-1368
2. Bell SJ, Rigby R, English N, Mann SD, Knight SC, Kamm MA, Stagg AJ (2001) Migration and maturation of human colonic dendritic cells. J Immunol 166: 4958-4967
3. Bocchia M, Bronte V, Colombo MP, De Vincentiis A, Di Nicola M, Forni G, Lanata L, Lemoli RM, Massaia M, Rondelli D, Zanon P, Tura S (2000) Antitumor vaccination: where we stand. Haematologica 85(11): 1172-1206
4. Chan RCF, Xie H, Zhao GP, Xie Y (2002) Dendritomas formed by fusion of mature dendritic cells with allogenic human hepatocellular carcinoma cells activate autologous cytotoxic T lymphocytes. Immunol Lett 83(2): 101-109
5. Chen YT, Gure RA, Tsang S, Stockert E, Jager E, Knuth A, Old LJ (1998) Identification of multiple cancer/testis antigens by allogenic antibody screening of a melanoma-cell line library. Proc Natl Acad Sci USA 95: 6919
6. Christ M, Lusky M, Stoeckel F, Dreyer D, Dieterie A, Michou AI, Pavirani A, Mehtail M (1997) Gene therapy with recombinant adenovirus vectors: evaluation of the host immune response. Immunology 57: 19-25
7. Dietz AB, Vuk-Pavlovic' S (1998) High efficiency adenovirus-mediated gene transfer to human dendritic cells. Blood 91: 392-398
8. Ertl HCJ, Xiang Z (1996) Novel vaccines approaches. J Immunol 156: 3579-3582
9. Gong J, Avigan D, Chen D, Wu Z, Koido S, Kashiwaba M, Kufe D (2000) Activation of antitumor cytotoxic T lymphocytes by fusion of human dendritic cells and breast carcinoma cells. Proc Natl Acad Sci USA 97: 2715-2718
10. Inaba K, Schuler G, Witmer MD, Valinsky J, Atassi B, Steinman RM (1986) Immunologic properties of purified epidermal Langerhans cells. Distinct requirements for stimulation of unprimed and sensitised T lymphocytes. J Exp Med 164: 605-613
11. Jäger D, Stockert E, Gure AO, Scanlan MJ, Karbach J, Jager E, Knuth A, Old LJ, Chen YT. (2001) Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library. Cancer Res 61: 2055-2061
12. Jager E, Nagata Y, Gnjatic S, Wada H, Stockert E, Kabach J, Dunbar PR, Lee SY, Jungbluth A, Jager D, Arand M, Ritter G, Cerundolo V, Dupont B, Chen YT, Old LJ, Knuth A. (2000) Monitoring CD8T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses. Proc Natl Acad Sci USA 97: 4760
13. Linette GP, Shankara S, Longerich S, Yang S, Doll R, Nicolette C, Preffer FI, Roberts BL, Haluska FG (2000) In vitro priming with adenovirus/gp100 antigen-transduced dendritic cells reveals the epitope specificity of HLA-A*0201-restricted CD8+ T cells in patients with melanoma. J Immunol 164: 3402-3412
14. Molnar-Kimber KL, Sterman DH, Chang M, Kang EH, Elbash M, Lanuti M, Elshami A, Gelfrand K, Wilson JM, Kaiser LR, Albelda SM (1998) Impact of pre-existing and induced humoral and cellular immune responses in an adenovirus-based gene therapy phase I clinical trial for localized mesothelioma. Hum Gene Ther 9: 2121-2133
15. Morse MA, Clay TM, Hobeika AC, Mosca PJ, Lyerly HK. (2001) Monitoring cellular immune responses to cancer immunotherapy. Curr Opin Mol Therapeut 3: 45-52
16. Ribas A, Butterfield LH, McBride WH, Jilani SM, Bui LA, Vollmer CM, Lau R, Dissett VB, Hu B, Chen AY, Glaspy JA, Economou JS (1997) Genetic immunization for the melanoma antigen MART-1/melan-A using recombinant adenovirus-transduced murine dendritic cells. Cancer Res 57: 2865-2869
17. Romani N, Koide S, Crowley M, Witmer-Pack M, Living stone AM, Fathman CG, Inaba K, Steinman RM (1989) Presenation of exogenous protein antigens by dendritic cells to T cell clones: intact protein is presented best by immature epidermal Langerhans cells. J Exp Med 169: 1169-1178
18. Rosenberg SA (1999) A new era for cancer immunotherapy based on the genes that encode cancer antigens. Immunity 10: 281
19. Sadanaga N, Nagashima H, Mashino K, Tahara K, Yamaguchi H, Ohta M, Fujie T, Tanaka F, Inoue H, Takesako K, Akiyoshi T, Mori M (2001) Dendritic cell vaccination with MAGE peptide is a novel therapeutic approach for gastrointestinal carcinomas. Clin Cancer Res 7: 2277-2284
20. Sallusto F, Lanzavecchia A (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and down-regulated by tumor necrosis factor α. J Exp Med 179: 1109-1118
21. Schuler M, Rochlitz C, Horowitz JA, Schlegel J, Perruchoud AP, Kommoss F, Bolliger CT, Kauczor HU, Dalquen P, Fritz MA, Swanson S, Herrmann R, Huber C (1998) A phase I study of adenovirus-medicated wild-type p53 gene transfer in patients with advanced non-small cell lung cancer. Hum Gene Ther 9(14): 2075-2082
22. Song W, Kong H, Carpenter H, Torii H, Granstein R, Rafii S, Moore MAS, Crystal RG (1997) Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model tumor antigen induce protective and therapeutic antitumor immunity. J Exp Med 186: 1247-1256
23. Steinman RM (1991) The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9: 271
24. Steinman RM, Hoffman L, Pope M (1995) Maturation and migration of cutaneous dendrtic cells. J Invest Dermatol 105: 2S-7S
25. 1, and p53 condon 249 mutation in hepatocellular carcinomas from guangxi, people's republic of china, and a meta-analysis of existing studies. Cancer Epidemiol Biomarkers Prevent 10: 617-625
26. Tahara K, Mori M, Sadanaga N, Sakamoto Y, Kitano S, Makuuchi M (1999) Expression of MAGE gene family in human hepatocellular carcinoma. Cancer 85: 1234
27. Tang ZY (1989) Efforts in the past decades to improve the ultimate outcome of primary liver cancer. In Primary Liver Cancer, Tang ZY (eds) pp 469-481. Beijing, China: China Academic Publishers
28. Timmerman JM, Levy R (1999) Dendritic cell vaccines for cancer immunotherapy. Annu Rev Med 50: 507-529
29. Verdijk RM, Mutis T, Esendam B, Kamp J, Melief CJ, Brand A, Goulmy E (1999) Polyribosinosinic polyribocytidlic (poly I:C) induces stable maturation of functionally active human dendritic cells. J Immunol 163: 57-61
30. Wan Y, Bramson J, Carter R, Graham F, Gauldie J (1997) Dendritic cells transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination. Hum Gene Ther 8: 1355-1363
31. Wang Y, Han KJ, Pang XW, Vaughan HA, Qu W, Dong XY, Peng JR, Zhao HT, Rui JA, Leng XS, Cebon J, Burgess AW, Chen WF (2002) Large scale identification of human hepatocellular carcinoma-associated antigens by autoantibodies. J Immunol 169: 1102-1109
32. 5 promote adenovirus internalization but not virus attachment. Cell 73: 309-319
33. Wilson JM, Engelhardt JF, Grossman M, Simon RH, Yang Y (1994) Gene therapy of cystic fibrosis lung disease using E1 deleted adenoviruses: a phase I trial. Hum Gene Ther 5(4): 501-519
34. Yamashita N, Ishibashi H, Hayashida K, Kudo J, Takenaka K, Itoh K, Niho Y (1996) High frequency of the MAGE-1 gene expression in hepatocellular carcinoma. Hepatology 24: 1437
35. Zhong L, Granelli-Piperno A, Choi YW, Steinman RM (1999) Recombinant adenovirus is an efficient and non-perturbing genetic vector for human dendritic cells. Eur J Immunol 29: 964-972